HomeCompareASCCF vs JNJ

ASCCF vs JNJ: Dividend Comparison 2026

ASCCF yields 0.93% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ASCCF wins by $3.53M in total portfolio value
10 years
ASCCF
ASCCF
● Live price
0.93%
Share price
$27.00
Annual div
$0.25
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.55M
Annual income
$2,939,082.90
Full ASCCF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ASCCF vs JNJ

📍 ASCCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodASCCFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ASCCF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ASCCF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASCCF
Annual income on $10K today (after 15% tax)
$78.70/yr
After 10yr DRIP, annual income (after tax)
$2,498,220.47/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ASCCF beats the other by $2,497,516.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASCCF + JNJ for your $10,000?

ASCCF: 50%JNJ: 50%
100% JNJ50/50100% ASCCF
Portfolio after 10yr
$1.78M
Annual income
$1,469,955.34/yr
Blended yield
82.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ASCCF
No analyst data
Altman Z
9.0
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASCCF buys
0
JNJ buys
0
No recent congressional trades found for ASCCF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricASCCFJNJ
Forward yield0.93%3.36%
Annual dividend / share$0.25$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR100%5.8%
Portfolio after 10y$3.55M$20.0K
Annual income after 10y$2,939,082.90$827.78
Total dividends collected$3.48M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ASCCF vs JNJ ($10,000, DRIP)

YearASCCF PortfolioASCCF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,885$185.19$10,676$355.77+$209.00ASCCF
2$12,024$376.78$11,407$389.39+$617.00ASCCF
3$13,644$777.94$12,198$426.53+$1.4KASCCF
4$16,249$1,649.95$13,056$467.62+$3.2KASCCF
5$21,059$3,672.87$13,987$513.12+$7.1KASCCF
6$31,430$8,897.57$14,998$563.56+$16.4KASCCF
7$58,453$24,821.89$16,098$619.52+$42.4KASCCF
8$148,829$86,284.54$17,295$681.69+$131.5KASCCF
9$569,888$410,641.42$18,599$750.82+$551.3KASCCF
10$3,548,863$2,939,082.90$20,022$827.78+$3.53MASCCF

ASCCF vs JNJ: Complete Analysis 2026

ASCCFStock

ASICS Corporation manufactures and sells sports goods in Japan, the Americas, Europe, Oceania, Southeast and South Asia, and internationally. It offers sports shoes, apparel, and equipment. The company sells its products under the ASICS, ASICSTIGER, and Onitsuka Tiger brands through 989 retail stores, as well as through online. ASICS Corporation was founded in 1949 and is headquartered in Kobe, Japan.

Full ASCCF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ASCCF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASCCF vs SCHDASCCF vs JEPIASCCF vs OASCCF vs KOASCCF vs MAINASCCF vs ABBVASCCF vs MRKASCCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.